Advertisement
Australia markets closed
  • ALL ORDS

    7,837.40
    -100.10 (-1.26%)
     
  • ASX 200

    7,575.90
    -107.10 (-1.39%)
     
  • AUD/USD

    0.6538
    +0.0015 (+0.23%)
     
  • OIL

    83.67
    +0.10 (+0.12%)
     
  • GOLD

    2,350.70
    +8.20 (+0.35%)
     
  • Bitcoin AUD

    98,631.42
    +1,469.80 (+1.51%)
     
  • CMC Crypto 200

    1,344.08
    -52.46 (-3.75%)
     
  • AUD/EUR

    0.6113
    +0.0039 (+0.65%)
     
  • AUD/NZD

    1.0981
    +0.0023 (+0.21%)
     
  • NZX 50

    11,805.09
    -141.34 (-1.18%)
     
  • NASDAQ

    17,687.30
    +256.79 (+1.47%)
     
  • FTSE

    8,139.70
    +60.84 (+0.75%)
     
  • Dow Jones

    38,263.15
    +177.35 (+0.47%)
     
  • DAX

    18,182.15
    +264.87 (+1.48%)
     
  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

Is It Too Late to Buy Vertex Pharmaceuticals Stock?

Is It Too Late to Buy Vertex Pharmaceuticals Stock?

Take Vertex Pharmaceuticals (NASDAQ: VRTX), a biotech that has delivered market-beating returns over the past decade. The drugmaker is still at it even amid the market downturn and currently sits near its 52-week high. Vertex has certainly been impressive, but are the company's best days already in the rearview mirror?